OSTRIVOMD Trademark
Trademark Overview
On Thursday, June 4, 2026, a trademark application was filed for OSTRIVOMD with the United States Patent and Trademark Office. The USPTO has given the OSTRIVOMD trademark a serial number of 99865461. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 4, 2026. This trademark is owned by Strivo MD LLC. The OSTRIVOMD trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Dietary and nutritional supplements; Dietary and nutritional supplements used for weight loss; Mixed hormone preparations; Hormones; Hormones for medical purposes; Hormone replacement therapy preparations; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment of hormonal disorders
Telemedicine services; Medical and pharmaceutical consultation; Clinical medical consultation services; Medical consultations; Providing information in the fields of health and wellness; Providing information in the fields of diet and weight loss via a website; Providing information in the field of diabetes; Providing information in the field of nutrition
General Information
| Serial Number | 99865461 |
| Word Mark | OSTRIVOMD |
| Filing Date | Thursday, June 4, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Thursday, June 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | The color(s) black and orange is/are claimed as a feature of the mark. |
| Goods and Services | Dietary and nutritional supplements; Dietary and nutritional supplements used for weight loss; Mixed hormone preparations; Hormones; Hormones for medical purposes; Hormone replacement therapy preparations; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment of hormonal disorders |
| Goods and Services | Telemedicine services; Medical and pharmaceutical consultation; Clinical medical consultation services; Medical consultations; Providing information in the fields of health and wellness; Providing information in the fields of diet and weight loss via a website; Providing information in the field of diabetes; Providing information in the field of nutrition |
| Description of Mark | The mark consists of the wording 'Ostrivo' in a stylized black font, where the dot of the 'i' is an orange circle. To the lower right of 'Ostrivo' is the wording 'MD' in orange. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 4, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 4, 2026 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Strivo MD LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Deerfield Beach, FL 33442
US |
Trademark Events
| Event Date | Event Description |
| Thursday, June 4, 2026 | NEW APPLICATION ENTERED |
| Thursday, June 4, 2026 | APPLICATION FILING RECEIPT MAILED |
